Patents Assigned to Ludwig Institute for Cancer Research Imperial College of Science, Technology & Medicine
  • Chemotactic cytokine
    Patent number: 6031080
    Abstract: A chemoattractant protein called "eotaxin" is capable of attracting eosinophils and of inducing eosinophil accumulation and/or activation in vitro and in vivo. Various types of agents that inhibit or otherwise hinder the production, release or activity of eotaxin may be used therapeutically in the treatment of asthma and other inflammatory diseases.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: February 29, 2000
    Assignee: Ludwig Institute for Cancer Research Imperial College of Science, Technology & Medicine
    Inventors: Timothy J. Williams, Peter J. Jose, David A. Griffiths-Johnson, John J. Hsuan